Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
IntroductionFibroblast growth factor 23 (FGF23), a potential biomarker for kidney function, is related to cardiovascular disease (CVD) and diabetes, although it is unclear whether the relation is causal. This study evaluated the associations of genetically predicted FGF23 with major CVDs, their risk...
Guardado en:
Autores principales: | Ying Liang, Shan Luo, C. Mary Schooling, Shiu Lun Au Yeung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2fdbabfacae42e594b1f479c839729d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Corrigendum: Genetically Predicted Fibroblast Growth Factor 23 and Major Cardiovascular Diseases, Their Risk Factors, Kidney Function, and Longevity: A Two-Sample Mendelian Randomization Study
por: Ying Liang, et al.
Publicado: (2021) -
Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: José Alberto Navarro-García, et al.
Publicado: (2021) -
Association of genetically predicted blood sucrose with coronary heart disease and its risk factors in Mendelian randomization
por: Ting Zhang, et al.
Publicado: (2020) -
Cyclooxygenase-2 and hypoxia-regulated proteins are modulated by basic fibroblast growth factor in acute renal failure
por: Villanueva,Sandra, et al.
Publicado: (2012) -
Eje somatotrópico y marcadores moleculares del metabolismo mineral en niños en diálisis
por: Ceballos Osorio,María Luisa, et al.
Publicado: (2017)